Immunostimulation before chemotherapy in cancer treatment

L. Frati, A. Barzi, M. C. Caprino, E. Menconi, E. Bonmassar

Research output: Contribution to journalArticlepeer-review

Abstract

Synergism between chemotherapy and immune responses has been evidenced in animals and man. In addition, non-specific immunostimulation seems to increase the efficiency of anticancer chemotherapy. Up to now most of the clinical trials have been conducted applying immunoadjuvants after initial chemotherapeutic treatment. Since presensitized immunocompetent cells are more radio- and chemo-resistant than non-stimulated lymphocytes, a trial of immunostimulation before chemotherapy is based on rational experimental basis. Such program, activated in humans during 1976, is conducted according to the following general scheme:o1.Chemotherapy alone2.Chemotherapy followed by BCG and recycle3.Chemotherapy preceded and followed by BCG and recycle. Protocols for breast, lung, colorectal and ovarian cancer treatment are described.

Original languageEnglish
Pages (from-to)689-699
Number of pages11
JournalPharmacological Research Communications
Volume9
Issue number8
DOIs
Publication statusPublished - 1977

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Immunostimulation before chemotherapy in cancer treatment'. Together they form a unique fingerprint.

Cite this